NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3080% above fair value
$26.16+0.27 (+1.06%)
Close on Nov 18, 2026Market cap $578.65MP/E –Yield 1.99%
NRC Health pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
NRC Health's pe ratio was 29.1× on Jan 30, 2026, against 14.8× a year earlier. Over the last 5 years it ranged from 10.9× to 39.1×, with a median of 28.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 29.1× | +2.2 |
| 2025 | Dec 31, 2025 | 26.8× | +11.2 |
| 2024 | Dec 31, 2024 | 15.6× | −18.5 |
| 2023 | Dec 29, 2023 | 34.1× | +7.1 |
| 2022 | Dec 30, 2022 | 27.0× | −2.4 |
| 2021 | Dec 31, 2021 | 29.4× | −3.2 |
| 2019 | Apr 30, 2019 | 32.7× | −0.2 |
| 2018 | Dec 31, 2018 | 32.8× | +24.8 |
| 2013 | Jul 31, 2013 | 8.0× | −4.2 |
| 2012 | Dec 31, 2012 | 12.2× | −7.8 |
| 2011 | Jan 31, 2011 | 19.9× | +0.0 |
| 2010 | Dec 31, 2010 | 19.9× | – |
See a number that looks wrong?